CARSON CITY, Nev., Feb. 6, 2012 /PRNewswire/ -- OphthaliX Inc. (OTCBB: OPLI) is pleased to announce the appointment of Professor Roger D. Kornberg to the Company's Board of Directors.

Scientists have deciphered the structure of an essential part of Mediator, a complex molecular machine that plays a vital role in regulating the transcription of DNA.

Nanometer-scale gold particles are currently intensively investigated for possible applications in catalysis, sensing, photonics, biolabeling, drug carriers and molecular electronics.

Nobel laureate Roger Kornberg, PhD, professor of structural biology at the Stanford University School of Medicine, will deliver the commencement address to the medical school's class of 2008 on June 14.

Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that Günter Blobel, M.D., Ph.D., has joined the Scientific Advisory Board of MDRNA, Inc., Nastech's wholly-owned subsidiary for the development of RNAi technology and therapeutics. Dr.